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Abstract
Background and aim: To report the six-month safety analyses among patients enrolled in the ‘‘Physical Fitness Training
in Subacute Stroke—PHYS-STROKE’’ trial and identify underlying risk factors associated with serious adverse events.
Methods: We performed a pre-specified safety analysis of a multicenter, randomized controlled, endpoint-blinded trial
comprising 200 patients with moderate to severe subacute stroke (days 5–45 after stroke) that were randomly assigned
(1:1) to receive either aerobic, bodyweight supported, treadmill-based training (n¼ 105), or relaxation sessions (n¼ 95,
control group). Each intervention session lasted for 25 min, five times weekly for four weeks, in addition to standard
rehabilitation therapy. Serious adverse events defined as cerebro- and cardiovascular events, readmission to hospital, and
death were assessed during six months of follow-up. Incident rate ratios (IRR) were calculated, and Poisson regression
analyses were conducted to identify risk factors for serious adverse events and to test the association with aerobic
training.
Results: Six months after stroke, 50 serious adverse events occurred in the trial with a higher incidence rate (per 100
patient-months) in the training group compared to the relaxation group (6.31 vs. 3.22; IRR 1.70, 95% CI 0.96 to 3.12).
The association of aerobic training with serious adverse events incidence rates were modified by diabetes mellitus (IRR
for interaction: 7.10, 95% CI 1.56 to 51.24) and by atrial fibrillation (IRR for interaction: 4.37, 95% CI 0.97 to 31.81).
Conclusions: Safety analysis of the PHYS-STROKE trial found a higher rate of serious adverse events in patients
randomized to aerobic training compared to control within six months after stroke. Exploratory analyses found an
association between serious adverse events occurrence in the aerobic training group with pre-existing diabetes mellitus
and atrial fibrillation which should be further investigated in future trials.
Data access statement: The raw data and analyses scripts are provided by the authors on a secure online repository
for reproduction of reported findings.
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The number of stroke survivors with impairments is
increasing, rendering effective rehabilitation interven-
tions a major unmet medical need.1 Aerobic training
is a recommended treatment modality in stroke
rehabilitation to counter cardiorespiratory deterior-
ation.2–4 However, it remains uncertain whether train-
ing in the critical early period of stroke recovery can be
carried out safely. Cardiorespiratory stress applied
during early rehabilitation might cause adverse effects.5
The evidence of safety of aerobic training early after
stroke is scarce. The latest Cochrane Collaboration
meta-analysis aggregated estimates of adverse effects
including cerebro- and cardiovascular events in the
stroke population but could not identify a higher risk
in aerobic training compared to control interventions.6
Of note, the evidence derived mainly from small studies
with limited reporting of adverse events.
Surprisingly and in contrast to smaller stroke
rehabilitation trials, the results of the recent ‘‘Physical
Fitness Training in Subacute Stroke’’ (PHYS-
STROKE) trial,7 which randomized subacute stroke
patients to early aerobic training or relaxation, identi-
fied a higher risk of serious adverse events (SAE) within
three months post stroke in the training group com-
pared to control.
Aims
In accordance with the trial protocol, we now report
the final safety data of the six-month trial follow-up
and additionally provide exploratory analyses aimed
to identify patient-related risk factors for SAE asso-
ciated with aerobic training. The six months’ follow-
up was chosen to unveil longer term effects of an
early aerobic training in the subacute phase after
stroke.
Methods
The trial protocol,8 statistical analysis plan (https://doi.
org/10.6084/m9.figshare.5375026.v1), and the primary
efficacy endpoints of the multi-center, randomized, con-
trolled PHYS-STROKE trial (clinicaltrials.gov identi-
fier: NCT01953549) were published previously.7 The
protocol was approved by the local ethics committee
of the Charité Universitätsmedizin Berlin (EA1/138/
13). Patients with either ischemic or hemorrhagic
stroke in the subacute phase (5–45 days post onset)
were included into the trial. The inclusion and exclusion
criteria of the trial are listed in the Supplementary
Table 1. All patients gave written informed consent.
Detailed intervention procedures have been previ-
ously described.7 In brief, patients were randomly
assigned to receive either bodyweight supported,
treadmill-based, aerobic training or relaxation sessions,
in addition to standard rehabilitation therapy over a
period of four weeks with five sessions per week á
25min each. The target heart rate (THR) in the training
group was calculated by the formula: 180 – ‘‘years of
age’’, which was hypothesized to approximate 50–60%
of each patient’s maximum heart rate. The THR was
reduced by 10 beats per minute in case of b-blocker
medication.9
Pre-defined safety endpoints included the following
SAE: recurrent non-fatal cardio- or cerebrovascular
event, readmission to an acute care hospital, or death
within six months post stroke. Cerebrovascular event
included any stroke or transient ischemic attack con-
firmed by cerebral imaging with or without clinical
manifestation that led to new ICD-10 diagnosis.
Readmission to an acute care hospital had to be con-
firmed by discharge letter.
All SAE occurring during hospitalization at the
rehabilitation clinic were monitored by a study site
physician and had to be reported within 24 h after
onset to the coordinating trial center. SAE that
occurred after discharge from hospital were inquired
from the trial participants or their relatives and con-
firmed by discharge letters during clinical follow-up
visits at three and six months post stroke. Access to
the population registry of Berlin was requested to
retrieve current health status for patients unavailable
at the six-month follow-up. Medical monitoring
appointed by the Center for Stroke Research Berlin
checked data fidelity and reporting of SAE at each
study site. An independent data and safety monitoring
board (DSMB) overlooked all SAE on a regular basis.
As part of the accompanying biomarker study
‘‘Biomarkers And Perfusion – Training-Induced
Changes After Stroke ’’ (BAPTISe), cerebral magnetic
resonance imaging (MRI) was acquired for a sub-
sample of patients (n¼ 110) before and after the
study intervention.10 New ischemic lesions visible on
diffusion-weighted imaging with or without clinical
manifestation were reported to the coordinating trial
center. In an exploratory framework, we analyzed rela-
tionships of SAE occurrence with patient characteris-
tics, pre-existing comorbidities, medication, and
pertinent blood biomarkers (details in supplementary
appendix). All comorbidities needed to have a formal
diagnosis issued with the respective ICD code at
baseline.
Descriptive summary statistics are presented as
mean and standard deviation (SD) or median and inter-
quartile range (IQR) where appropriate. The pre-
defined safety endpoints were analyzed using Poisson
regression models with individual observation time
until six months of follow-up as time at risk, which
allows for calculating incidence rates (IR) and incidence
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rate ratios (IRR) with 95% confidence intervals (CI).11
We calculated mixed Poisson regression models with
number of SAE as a dependent variable, treatment
arm as an independent variable, and a random effect
(random intercept) to account for center heterogeneity.
Additionally, we incorporated individual observation
times (log-transformed time of observation as offset).
Sensitivity analysis was performed without recurrent
strokes detected on cerebral MRI within the
BAPTISe study.
For our exploratory risk factor analysis, we fitted
multiple Poisson regression models to assess the asso-
ciation of preexisting comorbidities, treatment group,
and SAE. Models were controlled for age, sex, and
stroke severity to test robustness of associations.
Well-established cardiovascular risk factors, i.e. arterial
hypertension, atrial fibrillation, diabetes mellitus, his-
tory of cerebrovascular event, history of cardiac dis-
ease, number of comorbidities, and related medication
(antiplatelets, oral anticoagulants, b-blocker, and sta-
tins) were added to the models. Additionally, two-way
interaction terms with respective risk factors and treat-
ment group were tested. Decision on the final models
was based on Bayesian information criterion (BIC). This
was done to achieve parsimonious models with high
exploratory power, to avoid overfitting and to avoid
inclusion of highly correlated variables. Additionally,
to illustrate the direction of interaction effects, we used
estimated marginal means of subgroups from the final
model. Kaplan-Meier curves were used to verify found
associations and to illustrate time to first SAE in relevant
risk factor subgroups. All analyses are exploratory with
regard to the original analysis plan and were not cor-
rected for multiple testing (see Supplements).
Results
The PHYS-STROKE trial randomized 200 patients
(training, n¼ 105 vs. relaxation, n¼ 95) of which 190
(95%) were followed-up until six months post stroke
(Figure 1). Four patients of the training group (4%)
and six patients of the relaxation group (6%) were
lost to follow-up. Eight patients (training, n¼ 5 vs.
relaxation, n¼ 3) had to discontinue the intervention
due to SAE. Protocol adherence and baseline charac-
teristics can be found in Supplementary Tables 2 and 3.
Patients had a mean age of 69 years (SD 12 years) and
41% were females. Incident strokes were predomin-
antly ischemic (90%) with a median acute National
Institute of Health Stroke Scale (NIHSS) score of 8 (5
to 12). Patients randomly allocated to the training
group were more severely affected than patients in the
relaxation group (acute NIHSS: 9 (5–12) vs. 7 (5–11)).
Over the course of the trial, 50 SAE occurred in 39
patients. Fifteen recurrent cerebrovascular events and
30 readmissions to an acute care unit were observed.
Five patients died within the observation period
(training, n¼ 1 vs. relaxation, n¼ 4). All fatal events
took place after the intervention phase. No cardiovas-
cular event was recorded. Median time from start of
intervention to SAE occurrence was 41 days (IQR
14–111). Eighteen SAE (36%) appeared during the
intervention phase (training: eight strokes and six
readmissions; relaxation: four readmissions) but none
during an intervention session. Nine patients (training,
n¼ 6 vs. relaxation, n¼ 3) had more than one
SAE. Individual SAE are listed in the Supplementary
Table 4.
Recurrent cerebrovascular events were due to ische-
mic stroke (n¼ 13, 10 in the training and 3 in the relax-
ation group) or transient ischemic attacks (n¼ 2, one
per group). Five ischemic strokes (training, n¼ 4 vs.
relaxation, n¼ 1) were asymptomatic incidental find-
ings on baseline (n¼ 2) or post-intervention (n¼ 3)
MRI within the BAPTISe study. Hospital readmissions
primarily occurred because of cardiac complications
(27%) and are listed in the Supplementary Table 5. In
the training group, one patient died due to an urosepsis,
and in the relaxation group, two patients died from a
recurrent cerebral infarction, one from an acute aortic
dissection, and one cause remained unknown. All fatal
events were judged unrelated to the intervention by the
DSMB. Three recurrent ischemic events in the training
group were judged as ‘‘possibly although unlikely
related to the intervention’’; all other SAE were
judged ‘‘unlikely’’ to be related to the intervention.
Incidence rates for SAE from Poisson regression
analyses are presented in Table 1. Comparing aerobic
training with relaxation, within six months of follow-
up, the risk per 100 patient-months was 2.3 events and
0.9 events for recurrent cerebrovascular events (IRR:
2.43, 95% CI 0.83 to 8.76, p¼ 0.13), 4.3 and 2.1 for
readmission to an acute hospital (IRR 2.06, 95% CI
0.97 to 4.73, p¼ 0.07), and 0.11 and 0.93 for fatal
events (IRR of 0.22; 95% CI 0.01 to 1.50, p¼ 0.18),
respectively. Sensitivity analysis after exclusion of any
incidental MRI findings from the ‘‘BAPTISe’’ substudy
(n¼ 5) demonstrated similar IRR for cerebrovascular
events (IRR 2.06, 95% CI 0.58 to 9.59).
Distributions of patient characteristics with SAE
occurrence are displayed in the Supplementary Table
6. Unadjusted Poisson regression models identified a
higher risk of SAE in patients with vs. patients without
arterial hypertension in the training group compared to
the relaxation group. Similarly, this was observed for
patients with diabetes mellitus (DM), atrial fibrillation
(AF), higher hs-CRP, and higher serum cortisol.
We fitted multiple Poisson regression models with
respective preexisting comorbidities and cardiovascular
risk constellations and identified parsimonious models
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with best explanatory power (identified by BIC) analyz-
ing the association of DM and AF with SAE with an
interaction between treatment and DM (IRR for inter-
action 7.10, 95% CI 1.56 to 51.24; Figure 2(a)) and
between treatment and AF (IRR for interaction 4.37,
95% CI 0.94 to 31.81; Figure 2(b)), respectively, after
adjusting for age, sex, and NIHSS. Kaplan-Meier
curves illustrate the course of SAE occurrence for
DM and AF in Figure 3. Details of models and
model selection can be found in Supplementary Table
7. Due to the small number of SAE and due to colli-
nearities, it was not possible to derive one model includ-
ing the association of DM and AF with SAE in parallel.
Discussion
The results of this analysis from a randomized, con-
trolled stroke rehabilitation trial extends the current
knowledge of safety of an early bodyweight supported,
treadmill-based aerobic training after stroke and pro-
vides evidence of potential harms compared to a relax-
ation program in the early subacute phase after
moderate to severe stroke. We detected 50 SAE
within six months after stroke which corresponds to a
higher incidence rate of SAE than has been reported in
previous trials.6 Additionally, exploratory analyses
identified potential risk factors for SAE. When rando-
mized to the aerobic training group, patients with pre-
existing diabetes mellitus or atrial fibrillation had a
seven-fold or four-fold higher risk of experiencing
SAE, respectively. In contrast, risks for SAE were simi-
lar for patients without DM or without AF in both
intervention groups.
So far, aerobic training was deemed safe in the
stroke population.6 In our trial, SAE occurred more
frequently in the aerobic training group with a peak
Figure 1. Flow chart of patient enrollment and follow-up of the PHYS-STROKE trial.
Stroke patients admitted 
to rehabilitation sites (n = 12,866)
Randomized (n = 200)
Ineligible (n = 12,666)
5746 not seen by recruiter
6699 Not meeting inclusion criteria
51 Declined to participate
4 Screening failure
166 Other reasons





Dropouts (n = 4)
4 Lost-to-follow-up
Dropouts (n = 6)
6 Lost-to-follow-up
SAE prior to intervention
1 recurrent stroke
2 readmissions 
 • cardiac consultation
SAE prior to intervention
2 readmissions 
 • fall-related
SAE during intervention phase
8 recurrent strokes
6 readmissions 
 • fall-related 
 • respiratory complications
 • neurologic or 
 • cardiac consultation
SAE during intervention phase
4 readmissions 
 • cardiac consultation 
 • renal failure
SAE before discharge from trial site
1 recurrent stroke
2 readmissions 
 • endocrinologic consultation 
 • fall-related
SAE before discharge from trial site
1 recurrent stroke
1 readmission 
 • bladder tumor




 • detoriation of general 
               condition
 • renal failure
 • fall related
 • cardiac or 
 • gastroenterologic 
 consultation
1 death
SAE during outpatient follow-up
3 recurrent strokes
2 readmissions 
 • pneumonia 
 • psychiatric consultation
4 deaths
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during the intervention phase. Particularly, recurrent
cerebrovascular events happened in temporal relation
with the training intervention, whereas patients in the
relaxation group had no similar event.
Case fatality rates were lower in the training group after
six months of follow-up compared to the relaxation group.
A detailed risk assessment of aerobic training is
urgently needed, given that guidance for carers of
Figure 2. Model-based estimates of events in subgroups of SAE for status of DM (a) and AF (b) in both treatment groups per
100 patient-months. Estimated marginal means are calculated from Poisson regression with Treatment, respective comorbidity,
b-blocker medication and an interaction term for treatment with respective comorbidity and are adjusted for age, sex and NIHSS.











































Model-based estimates of serious adverse events











































Model-based estimates of serious adverse events
and status of atrial fibrillation
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Note: Incidence rates (per 100 patient-months) and incidence rate ratios of serious adverse events between both intervention groups.
International Journal of Stroke, 0(0)
Rackoll et al. 5
stroke patients remains contradictory and does not sys-
tematically account for individual patient characteris-
tics.2–4,12,13 So far, adverse events are rarely reported in
stroke rehabilitation trials investigating aerobic train-
ing, and associations of adverse events with comorbid-
ities are not discussed.6 In fact, only 4 out of 17 trials
on aerobic, treadmill-based exercise in the latest
Cochrane review reported preexisting comorbidities of
study participants in their publications, and in only
seven publications, SAE assessment was described.6
None of these reports tested for an association of spe-
cific patient characteristics and SAE occurrence. The
PHYS-STROKE trial, however, reported a possible
relation of patient characteristics to SAE occurrence
for the first time and aimed to identify subgroups of
patients with higher risk.
Diabetic patients are at higher risk for recurrent vas-
cular events and poor outcome after stroke compared
to patients without diabetes.14 We found a higher asso-
ciation of DM with aerobic exercise in our study popu-
lation. To the best of our knowledge, no literature
exists investigating the risk of aerobic training in
stroke patients with DM.
Presence of AF was associated with a higher risk of
SAE occurrence in patients undergoing aerobic exercise
in the present study. In general, patients with AF dem-
onstrate a high risk of stroke.15 Literature on tolerabil-
ity of aerobic training in stroke patients with AF is
scarce. So far, exercise is recommended for all patients
with AF, but large exercise intervention studies with
assessment on safety are still missing.16 In a meta-ana-
lysis of exercise rehabilitation trials comprising patients
with AF but without stroke, aerobic exercise was con-
sidered safe.17 The American Association of
Cardiovascular and Pulmonary Rehabilitation recom-
mends to slowly progress in exercise intensity in early
cardiac rehabilitation.18 This may be also applicable in
early stroke rehabilitation for patients with concomi-
tant AF, a hypothesis to be explored systematically in
future trials.
The PHYS-STROKE trial entails the largest number
of subacute stroke patients receiving aerobic training
within a randomized clinical trial so far, but several
limitations should be considered when interpreting
our findings: First, the PHYS-STROKE trial was not
powered to detect SAE. However, our trial was the first
large study to conduct aerobic training in moderate to
severe subacute stroke patients. Further research with
rigorous reporting on adverse events is necessary.
Second, despite randomization, stroke severity was
not balanced between both treatment arms. Patients
in the training group had more severe strokes as indi-
cated by the NIHSS, which might have put patients at
higher risk for SAE. However, NIHSS score was not
substantially associated with SAE occurrence after
adjustment for other covariates. Third, we used a prag-
matic approach in our trial to assess THR of patients
which may have over- or under-estimated the THR that
would have been elicited by gradual exercise testing.
Therefore, associations between intensity of aerobic
training and rate of adverse events should be inter-
preted with caution. Fourth, the exact mechanisms
underlying SAE occurrence following aerobic training
cannot be determined in our study. Tentatively, SAE
occurrence might also be related to preexisting comor-
bidities (see Supplementary Tables 3 and 4). However,
comorbidities were similarly high in both intervention
groups. Fifth, information on risk factors associated
with cardiovascular events such as level of previous
physical activity or diet were not assessed in the
PHYS-STROKE trial. Although data on pre-stroke
behavior might be vital, assessment of such measures
are subject to recall bias. Lastly, our trial incorporated
a rigorous training regimen with training sessions five
Figure 3. Kaplan–Meier curve of cumulated SAE occurrence stratified by DM (a) and AF (b) status over time. Interactions are























Kaplan-Meier curve for cumulative events in patients 
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Kaplan-Meier curve for cumulative events in patients 
with and without atrial fibrillation
Groups Training & AF    Training, no AF        Relaxation & AF        Relaxation, no AF
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times per week over a four-week period. A slower pro-
gression of training intensity might be necessary to
reduce potential risks in a vulnerable patient population.
Aerobic fitness training early after moderate to
severe stroke may cause harm compared to relaxation,
and increased risk of SAE was particularly attributed to
patients with preexisting diabetes mellitus or atrial fib-
rillation in the PHYS-STROKE trial. Future trials are
needed to confirm or refute these exploratory findings.
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